Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Neoleukin Therapeutics, Inc. Common Stock (NLTX)

Pharmaceutical Preparations

https://www.neoleukin.com

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefits over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises NL-201, which is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding.

SUITE 360 - 1616 EASTLAKE AVE EAST
SEATTLE, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/07/2014

Market Cap

8,199,685

Shares Outstanding

9,400,000

Weighted SO

2,349,475

Total Employees

N/A

Upcoming Earnings

03/19/2024

Similar Tickers

CTMX --.--%

SPRO --.--%

TIL --.--%

NXTC --.--%

ASMB --.--%

ACHL --.--%

NUVB --.--%

Beta

1.1020

Last Div

0.0000

Range

3.42-18.8

Chg

0.0500

Avg Vol

5520

Mkt Cap

8199685

Exch

NASDAQ

Country

US

Phone

855 226 6447

DCF Diff

2.5884

DCF

3.5984

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.2171

P/FV

0.5150

Div Yield %

0.0000

P/E

-0.9844

PEG

-0.2087

Payout

0.0000

Current Ratio

15.3287

Quick Ratio

15.0627

Cash Ratio

4.8400

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.1488

ROA

-0.4393

ROE

-0.4764

ROCE

-0.4506

NI/EBT

1.1488

EBT/EBIT

0.9011

EBIT/Rev

0.0000

Debt Ratio

0.1194

D/E

0.1421

LT Debt/Cap

0.1083

Total Debt/Cap

0.1244

Int Coverage

330.6174

CF/Debt

-3.0192

Equity Multi

1.1907

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.9081

FCF/Share

-2.9671

Cash/Share

7.0718

OCF/Sales

0.0000

FCF/OCF

1.0203

CF Coverage

-3.0192

ST Coverage

-20.7748

CapEx Coverage

-49.2885

Div&CapEx Cov

-49.2885

P/BV

0.5150

P/B

0.5150

P/S

0.0000

P/E

-0.9844

P/FCF

-0.2489

P/OCF

-1.2001

P/CF

-1.2001

PEG

-0.2087

P/S

0.0000

EV Multiple

0.2171

P/FV

0.5150

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 14, 19:00 Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split GlobeNewswire Inc. Dec 14, 19:00 Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

Revenue Product Segmentation